The Patent Finder

Lymphotec Inc.

Also on record
Records under this name other than the patents Lymphotec Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 1 patents it holds.

Showing 1 to 4 of 4 · Back to Lymphotec Inc.

PatentTitleStatus Expires Confidence
US 8,394,368Method for producing a composition for promoting survival of transplanted hematopoietic stem cell
Term ended
Ended no later than May 26, 2024 · From the USPTO record
Term endedEnded no later than May 26, 2024From the USPTO record
US 6,692,958Cord blood-derived activated lymphocytes, preparations containing said lymphocytes as main ingredient and method and kit for producing said preparations
Term ended
Term ended Dec 23, 2021 · From the USPTO record
Term endedTerm ended Dec 23, 2021From the USPTO record
US 7,105,155Method and activated lymphocyte preparations for preventing recurrence of carcinoma
Term ended
Term ended Sep 4, 2021 · From the USPTO record
Term endedTerm ended Sep 4, 2021From the USPTO record
US 6,544,514Compositions comprising, as the main ingredient, allogenic activated-C4+ cells and method for producing and using the same
Term ended
Term ended May 22, 2019 · From the USPTO record
Term endedTerm ended May 22, 2019From the USPTO record
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited